Guidance Archives - Page 53 of 637

1 minute read

Garmin’s Advanced Wearables Are In Demand, Surprises With Q1 Profit Growth

May 1, 9:47 AM

Garmin reported Q1 2024 results with 20% revenue growth, beating consensus. Fitness, Outdoor, Marine, and Auto segments all saw growth. Dividend and FY24 outlook were reiterated.

GRMN

2 minute read

DuPont De Nemours Reports Mixed First Quarter, Sees Hope On The Horizon

By Akanksha Bakshi

May 1, 9:43 AM

DuPont reported Q1 fiscal 2024 sales decline of 3% to $2.031B, beating consensus. Organic sales fell 6%. Q2 outlook: $3.025B sales, $0.84 EPS. 2024 outlook raised: $3.45-$3.75 EPS, $12.1B-$12.4B revenue.

2 minute read

GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook

By Vandana Singh

May 1, 9:42 AM

Discover GSK's first-quarter performance, boasting a 10% Y/Y sales surge to £7.4 billion. Notable growth in Vaccines and Specialty Medicines, propelled by strong demand for Arexvy and Shingrix. Expectations soar with raised 2024 EPS and sales forecasts.

BNTX

2 minute read

Kraft Heinz Faces Revenue Slump In Q1, CEO Remains Optimistic On Growth Plan

By Shivani Kumaresan

May 1, 9:09 AM

Explore Kraft Heinz Company's Q1 FY24 performance: Revenue misses street estimates, with a 1.2% sales decline. Despite challenges, gross profit rises by 6.2%, signaling operational resilience. CEO Abrams-Rivera emphasizes strategic reinvestments fueling innovation, brand strength, and growth.

KHC

2 minute read

Rising Cost For Health Insurers Bites CVS Health’s Q1 Profit, Stock Tanks

By Vandana Singh

May 1, 8:52 AM

CVS Health Q1 sales of $88.4 billion, up 3.7% Y/Y. Adjusted EPS at $1.31, down from $2.20. Health Care Benefits segment sees strong growth, while Health Services segment faces challenges. Revised 2024 guidance reflects continued pressure on earnings.

CVS

2 minute read

Why Are Cosmetics Major Estee Lauder’s Shares Diving Today?

By Shivani Kumaresan

May 1, 8:45 AM

Estee Lauder Companies faces stock dip on EPS guidance miss. Despite a 5% YoY sales growth in Q3, below-estimate outlooks weigh. Organic net sales up 6%, driven by strong EMEA performance.

1 minute read

Extreme Networks Expects FY24 Net Revenue of $1.1105B-$1.1205B Vs $1.125B Est, Adj EPS of $0.51-$0.55 Vs $0.57 Est

By Benzinga Newsdesk

May 1, 7:14 AM

Business Outlook: Extreme's business outlook is based on current expectations. The following statements are forward-looking, and actual results could differ materially based on various factors,

EXTR

2 minute read

CORRECTION: Estée Lauder Companies Q4 Outlook: Adj. EPS $0.18 – $0.28 Vs. $0.75 Estimate, Revenue Growth +5% – +9%

By Benzinga Newsdesk

May 1, 7:12 AM

Fourth Quarter Fiscal 2024 Sales Outlook Reported net sales are forecasted to increase between 5% and 9% versus the prior-year period. Currency exchange rates are volatile and difficult to predict. Using March

1 minute read

Extreme Networks Expects Q4 Revenue of $250.0M-$260.0M Vs $271.21M Est, Adj EPS of $0.11-$0.15 Vs $0.15 Est

By Benzinga Newsdesk

May 1, 7:11 AM

Business Outlook: Extreme's business outlook is based on current expectations. The following statements are forward-looking, and actual results could differ materially based on various factors,

EXTR

1 minute read

ProPetro’s For 2024 Expects Incurred Capital Expenditures To Be On The Low End Of $200M-$250M; For Q2 Expects Frac Fleet Effective Utilization To Be Between 14 To 15 Fleets

By Benzinga Newsdesk

May 1, 7:09 AM

Guidance The Company now expects to be on the low end of our prior guidance range for full-year 2024 incurred capital expenditures of $200 million to $250 million. Frac fleet effective

PUMP